130 related articles for article (PubMed ID: 7647004)
1. CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells.
Bianchi A; Montacchini L; Barral P; Borrione P; Attisano C; Orsini E; Boccadoro M; Pileri A; Massaia M
Br J Haematol; 1995 Jul; 90(3):625-32. PubMed ID: 7647004
[TBL] [Abstract][Full Text] [Related]
2. Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.
Massaia M; Attisano C; Peola S; Montacchini L; Omedé P; Corradini P; Ferrero D; Boccadoro M; Bianchi A; Pileri A
Blood; 1993 Sep; 82(6):1787-97. PubMed ID: 8400233
[TBL] [Abstract][Full Text] [Related]
3. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
Finck BK; Yung CM; Carteron NL; Wofsy D
Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
[TBL] [Abstract][Full Text] [Related]
4. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
[TBL] [Abstract][Full Text] [Related]
5. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
Campbell SB; Komata T; Kelso A
Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
[TBL] [Abstract][Full Text] [Related]
8. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antigen-specific responses using in vitro enriched T cells.
Jones N; Agrawal D; Elrefaei M; Hanson A; Novitsky V; Wong JT; Cao H
J Immunol Methods; 2003 Mar; 274(1-2):139-47. PubMed ID: 12609540
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells.
Jin Y; Fuller L; Carreno M; Esquenazi V; Blomberg BB; Wei YT; Ciancio G; Burke GW; Tzakis A; Ricordi C; Miller J
Hum Immunol; 2002 Jul; 63(7):567-75. PubMed ID: 12072192
[TBL] [Abstract][Full Text] [Related]
11. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
12. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
13. Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis.
Attisano C; Bianchi A; Montacchini L; Carlesso N; Peola S; Bruno B; Roux V; Ferrero D; Gallo E; Boccadoro M
Br J Haematol; 1994 Jul; 87(3):494-502. PubMed ID: 7993789
[TBL] [Abstract][Full Text] [Related]
14. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
15. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
16. Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients.
Tani M; Tanimura H; Yamaue H; Mizobata S; Iwahashi M; Tsunoda T; Noguchi K; Tamai M; Hotta T; Terasawa H
Int J Cancer; 1995 Mar; 60(6):802-7. PubMed ID: 7896449
[TBL] [Abstract][Full Text] [Related]
17. Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.
Janssen RA; Heijn AA; The TH; de Leij L
Cancer Immunol Immunother; 1994 Jan; 38(1):53-60. PubMed ID: 8299119
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
20. Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes.
Su DM; Wang J; Lin Q; Cooper MD; Watanabe T
Immunology; 1997 Apr; 90(4):543-9. PubMed ID: 9176107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
